• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Triple combination therapy for pancreatic cancer remodels stroma and improves survival.

作者信息

Vázquez-Arreguín Karina, Kaur Balveen

机构信息

Department of Pathology and Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA, USA.

出版信息

Mol Ther Oncolytics. 2023 Mar 21;29:15-16. doi: 10.1016/j.omto.2023.03.001. eCollection 2023 Jun 15.

DOI:10.1016/j.omto.2023.03.001
PMID:36992913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10041460/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76cd/10041460/c7c702b3312d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76cd/10041460/c7c702b3312d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76cd/10041460/c7c702b3312d/gr1.jpg

相似文献

1
Triple combination therapy for pancreatic cancer remodels stroma and improves survival.胰腺癌三联组合疗法可重塑基质并提高生存率。
Mol Ther Oncolytics. 2023 Mar 21;29:15-16. doi: 10.1016/j.omto.2023.03.001. eCollection 2023 Jun 15.
2
Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.沉默 PCBP2 可使促结缔组织增生性基质正常化，并提高胰腺癌化疗的抗肿瘤活性。
Theranostics. 2021 Jan 1;11(5):2182-2200. doi: 10.7150/thno.53102. eCollection 2021.
3
Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours.肿瘤基质靶向型一氧化氮纳米凝胶逆转胰腺纤维形成，克服胰腺肿瘤对 TRAIL 的耐药性。
Gut. 2022 Sep;71(9):1843-1855. doi: 10.1136/gutjnl-2021-325180. Epub 2021 Dec 17.
4
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy.同时抑制 hedgehog 信号通路和肿瘤增殖可重塑基质并增强胰腺癌治疗效果。
Biomaterials. 2018 Mar;159:215-228. doi: 10.1016/j.biomaterials.2018.01.014. Epub 2018 Jan 9.
5
PROGNOSTIC VALUE OF TUMOR STROMA RATIO IN TRIPLE NEGATIVE BREAST CANCER.肿瘤基质比在三阴性乳腺癌中的预后价值。
Wiad Lek. 2021;74(3 cz 2):565-571.
6
Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation.三重复合 miRNA 抑制 VEGFRs 通过 EMT 调控增强胰腺癌化疗疗效。
J Control Release. 2017 Jan 10;245:1-14. doi: 10.1016/j.jconrel.2016.11.024. Epub 2016 Nov 23.
7
The prognostic value of tumour-stroma ratio in triple-negative breast cancer.肿瘤间质比在三阴性乳腺癌中的预后价值。
Eur J Surg Oncol. 2012 Apr;38(4):307-13. doi: 10.1016/j.ejso.2012.01.002. Epub 2012 Jan 20.
8
Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells.新辅助治疗通过耗竭促肿瘤免疫细胞重塑胰腺癌微环境。
Clin Cancer Res. 2020 Jan 1;26(1):220-231. doi: 10.1158/1078-0432.CCR-19-1864. Epub 2019 Oct 4.
9
Overexpression of carbohydrate sulfotransferase 15 in pancreatic cancer stroma is associated with worse prognosis.胰腺癌基质中碳水化合物硫酸转移酶15的过表达与较差的预后相关。
Oncol Lett. 2019 Oct;18(4):4100-4105. doi: 10.3892/ol.2019.10764. Epub 2019 Aug 16.
10
Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.靶向胰腺癌中的基质：靶向治疗的前景与失败
J Cell Physiol. 2017 Nov;232(11):2931-2937. doi: 10.1002/jcp.25798. Epub 2017 Mar 31.

引用本文的文献

1
Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3.胰腺癌细胞系对临床批准的黏着斑激酶（FAK）抑制剂的敏感性：通过与溶瘤性柯萨奇病毒B3联合增强细胞毒性
Int J Mol Sci. 2025 Jul 17;26(14):6877. doi: 10.3390/ijms26146877.

本文引用的文献

1
Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors.使用粘着斑激酶抑制剂联合G47Δ和免疫检查点抑制剂克服富含基质的胰腺癌的耐药性。
Mol Ther Oncolytics. 2022 Dec 7;28:31-43. doi: 10.1016/j.omto.2022.12.001. eCollection 2023 Mar 16.
2
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.德法替尼、帕博利珠单抗和吉西他滨治疗晚期治疗难治性胰腺癌患者的 I 期剂量递增和扩展研究。
Clin Cancer Res. 2022 Dec 15;28(24):5254-5262. doi: 10.1158/1078-0432.CCR-22-0308.
3
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.
瘤内溶瘤单纯疱疹病毒 G47∆ 治疗残留或复发性脑胶质瘤：一项 2 期试验
Nat Med. 2022 Aug;28(8):1630-1639. doi: 10.1038/s41591-022-01897-x. Epub 2022 Jul 21.
4
The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics.整合素与溶瘤单纯疱疹病毒1在高级别胶质瘤治疗中的复杂关系。
Mol Ther Oncolytics. 2022 Jun 6;26:63-75. doi: 10.1016/j.omto.2022.05.013. eCollection 2022 Sep 15.
5
The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.核焦点黏着激酶（FAK）在癌症中的作用：聚焦综述。
J Exp Clin Cancer Res. 2019 Jun 11;38(1):250. doi: 10.1186/s13046-019-1265-1.
6
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966.用整合素 β1 阻断抗体 OS2966 增强溶瘤单纯疱疹病毒-1 的治疗效果。
Mol Cancer Ther. 2019 Jun;18(6):1127-1136. doi: 10.1158/1535-7163.MCT-18-0953. Epub 2019 Mar 29.
7
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.靶向粘着斑激酶可使胰腺癌对检查点免疫疗法产生反应。
Nat Med. 2016 Aug;22(8):851-60. doi: 10.1038/nm.4123. Epub 2016 Jul 4.
8
Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma.细胞外基质蛋白 CCN1 限制胶质母细胞瘤的溶瘤疗效。
Cancer Res. 2012 Mar 15;72(6):1353-62. doi: 10.1158/0008-5472.CAN-11-2526. Epub 2012 Jan 26.
9
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy.肿瘤微环境调节对溶瘤病毒治疗疗效的影响。
J Natl Cancer Inst. 2007 Dec 5;99(23):1768-81. doi: 10.1093/jnci/djm229. Epub 2007 Nov 27.
10
Focal adhesion kinase plays a pivotal role in herpes simplex virus entry.粘着斑激酶在单纯疱疹病毒进入过程中起关键作用。
J Biol Chem. 2005 Sep 2;280(35):31116-25. doi: 10.1074/jbc.M503518200. Epub 2005 Jul 1.